Antituberculosis agents - II. Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole derivatives

被引:64
作者
Foroumadi, A
Mirzaei, M
Shafiee, A [1 ]
机构
[1] Univ Tehran Med Sci, Fac Pharm, Dept Med Chem, Tehran, Iran
[2] Kerman Univ Med Sci, Fac Pharm, Dept Med Chem, Kerman, Iran
来源
FARMACO | 2001年 / 56卷 / 08期
关键词
antituberculosis agents; minimum inhibitory concentration; cytotoxicity;
D O I
10.1016/S0014-827X(01)01099-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Using the radiometric BACTEC 460-TB methodology, the minimum inhibitory concentration (MIC) of a series of 2-(1-methyl-5-nitro-2-imidazolyl-1,3,4-thiadiazole'-5-alkylsulfides, alkylsulfoxides and alkylsulfones which had been reported previously as antifungal agents, were determined. Active compounds were also screened by serial dilution to assess toxicity to a VERO cell line. The results indicate that compounds bearing a primary alkylthio substitution displayed good antituberculosis activity (MIC 3.13-6.25 mug/ml). Oxidation to sulfone abolished the antituberculosis activity in methyl and propyl derivatives while the ethylsulfonyl analogue was active (MIC = 1.56 mug/ml). The cytotoxic effects indicate that 2-(1-methyl-5-nitro-2-imidazolyl)-5-methylthio-1,3,4-thiadiazole was the least toxic compound (IC(50) > 10 mug/ml). Generally, all compounds showed a low selectivity index. (C) 2001 Elsevier Science S.A. All rights reserved.
引用
收藏
页码:621 / 623
页数:3
相关论文
共 10 条
[1]  
ASHOUR FA, 1990, FARMACO, V45, P134
[2]  
Ates Ö, 2000, ARZNEIMITTEL-FORSCH, V50, P569
[3]   2-AMINO-5-(1-METHYL-5-NITRO-2-IMIDAZOLYL)-1,3,4-THIADIAZOLE - A NEW ANTIMICROBIAL AGENT [J].
BERKELHA.G ;
ASATO, G .
SCIENCE, 1968, 162 (3858) :1146-&
[4]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009
[5]  
Foroumadi A., 1998, Pharmacy and Pharmacology Communications, V4, P95
[6]  
FOROUMADI A, 2001, IN PRESS PHARMAZIE
[7]  
HARDMAN JG, 1996, GOODMAN GILMANS PHAR, P1155
[9]   ANTITUBERCULOSIS AGENTS .5. ALPHA-[5-(5-NITRO-2-FURYL)-1,3,4-OXADIAZOL-2-YLTHIO]ACETHYDRAZIDE AND RELATED-COMPOUNDS [J].
MIR, I ;
SIDDIQUI, MT ;
COMRIE, AM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (06) :548-550
[10]   DRUG-RESISTANT TUBERCULOSIS IN THE 1990S [J].
YEW, WW ;
CHAU, CH .
EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (07) :1184-1192